Rapid desensitization for brentuximab vedotin (Adceteris ®) allergy: a case report

Brentuximab vedotin (BV) is an antibody –drug conjugate formed by an anti-CD30 chimeric IgG1 conjugated with monomethyl-auristatin-E. BV targets the CD30+ cells, which characterize Hodgkin lymphoma as well as anap...

Source: Clinical and Molecular Allergy - October 29, 2018 Category: Allergy & Immunology Authors: Attilio Di Girolamo, Marcello Albanesi, Alessandro Sinisi, Eustachio Nettis, Danilo Di Bona, Maria Filomena Caiaffa and Luigi Macchia Tags: Case Report Source Type: research